ID
36624
Descrição
Study ID: 102394 Clinical Study ID: 102394 Study Title: A Phase IV, partially double-blind study to demonstrate non-inferiority of GSK Biologicals’ Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process) when administered as a single dose to subjects aged 2-30 yrs Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00227422 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results Generic Name: Meningococcal Serogroups A, C, W-135 and Y Vaccine Trade Name: Mencevax Study Indication: Infections, Meningococcal
Link
http://www.pfizer.com/research/clinical_trials/trial_data_and_results
Palavras-chave
Versões (1)
- 26/05/2019 26/05/2019 -
Titular dos direitos
GlaxoSmithKline
Transferido a
26 de maio de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process); NCT00227422
Concomitant Vaccination
- StudyEvent: ODM
Similar models
Concomitant Vaccination
- StudyEvent: ODM
C0042196 (UMLS CUI-2)
C0042196 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])